Skip to main content
. 2019 Jan 31;111(9):933–942. doi: 10.1093/jnci/djy224

Table 1.

Multiple regression analysis of relationships between ERα expression and clinical characteristics*

Clinical characteristic All TCGA HNSC
OPSC-CR
Ratio of ERα mRNA (95% CI) P * OR for ERα-positive/negative (95% CI) P *
HPV status
 Negative 1.00 (Referent) 1.00 (Referent)
 Positive 3.71 (2.57 to 5.36) <.001 4.04 (1.26 to 13.01) .02
N classification
 <N2b 1.00 (Referent) 1.00 (Referent)
 ≥N2b 0.75 (0.57 to 0.98) .04 1.85 (0.97 to 3.54) .06
Sex
 Male 1.00 (Referent) 1.00 (Referent)
 Female 1.17 (0.91 to 1.50) .22 2.00 (0.87 to 4.60) .1
Primary site tonsil
 No 1.00 (Referent) 1.00 (Referent)
 Yes 0.90 (0.57 to 1.43) .66 1.44 (0.75 to 2.75) .27
Smoker
 Never 1.00 (Referent) 1.00 (Referent)
 Ever 0.76 (0.59 to 0.98) .03 0.73 (0.37 to 1.44) .36
Age, y
 ≤60 1.00 (Referent) 1.00 (Referent)
 >60 1.04 (0.84 to 1.29) .70 1.21 (0.60 to 2.44) .59
Metastasis at presentation
 No 1.00 (Referent) 1.00 (Referent)
 Yes 0.80 (0.31 to 2.07) .65 0.88 (0.26 to 2.91) .83
T classification
 T≤2 1.00 (Referent) 1.00 (Referent)
 T >2 1.17 (0.90 to 1.52) .25 0.92 (0.45 to 1.87) .82
Alcohol abuse
 No 1.00 (Referent)
 Yes 0.83 (0.34 to 2.04) .69
Keratinizing tumor
 No 1.00 (Referent)
 Yes 0.45 (0.20 to 0.99) .048
*

P values were calculated using two-sided Wald tests. For The Cancer Genome Atlas (TCGA) head and neck squamous carcinoma (HNSC) cohort, multiple linear regression of log-transformed mRNA levels against the indicated variables; relationships with clinical variables are expressed as mRNA expression ratios on the nontransformed scale. For oropharyngeal squamous carcinoma chemoradiation (OPSC-CR) cohort, multiple logistic regression of positive/negative immunohistochemical staining against the indicated variables. CI = confidence interval; ERα = estrogen receptor α; OR = odds ratio.